Teddi Mellencamp mencari obat penurun berat badan di tengah perjuangan melawan kanker stadium 4

Teddi Mellencamp, mantan bintang Real Housewives of Beverly Hills, mengungkapkan dalam podcast-nya bahwa ia memohon kepada dokternya untuk diberikan obat penurun berat badan GLP-1 saat berjuang melawan kanker. Berat badannya bertambah akibat steroid, namun permintaannya ditolak. Sambil bercanda mengenai ironi tersebut, ia melontarkan komentar jenaka tentang menjalani hidup terbaiknya tanpa bantuan obat tersebut.

Tunggu dulu—Teddi Mellencamp baru saja mengungkapkan cerita jujur dalam podcast 'Two Ts In A Pod'. 😲 Bintang reality show ini mengakui bahwa ia meminta GLP-1 kepada dokternya setelah steroid menyebabkan kenaikan berat badan selama perjuangannya melawan melanoma stadium 4. Namun, dokternya menolak, yang membuatnya merasa frustrasi dengan jenaka: 'Anda menyuruh saya untuk menjalani hidup terbaik saya... tapi di mana GLP-1 saya?' 👀

Artikel Terkait

Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Gambar dihasilkan oleh AI

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Dilaporkan oleh AI Gambar dihasilkan oleh AI Fakta terverifikasi

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Women taking GLP-1 medications such as Ozempic and Wegovy showed about 30 percent lower odds of developing breast cancer in a large observational study.

Dilaporkan oleh AI

Scientists have developed a hybrid obesity treatment that uses GLP-1 and GIP signals to deliver a metabolic enhancer directly into cells. Early tests in mice showed greater weight loss and better blood sugar control than standard therapies. The approach aims to reduce side effects by limiting the drug's action to targeted areas.

Brandi Glanville jumped to Lisa Vanderpump's defense on the latest episode of her podcast. She called out Scheana Shay for writing 'horrible things' about Vanderpump in her memoir. Glanville highlighted Vanderpump's past kindness toward Shay.

Dilaporkan oleh AI

A large study tracking nearly 100,000 people in Sweden found that GLP-1 receptor agonists like semaglutide, sold as Ozempic and Wegovy, are associated with significantly fewer psychiatric hospital visits and reduced sick days due to mental health issues. Researchers observed drops of up to 47% in various mental health risks during drug use periods. The findings appear in The Lancet Psychiatry.

Situs web ini menggunakan cookie

Kami menggunakan cookie untuk analisis guna meningkatkan situs kami. Baca kebijakan privasi kami untuk informasi lebih lanjut.
Tolak